FDA Adverse Event Death Summary report: N

PULSE GEN MODEL 101

MDR report key: 746364 · Received August 11, 2006

Report

Report Number
1644487-2006-00284
Event Type
Death
Date Received
August 11, 2006
Date of Event
June 13, 2006
Report Date
July 13, 2006
Manufacturer
CYBERONICS, INC.
Product Code
LYJ
PMA / PMN Number
P970003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TREATING PHYSICIAN INDICATED THAT, THE NCP SYSTEM WAS NOT RELATED TO THE CAUSE OF DEATH.

Description of Event or Problem · 1

REPORTER INDICATED THAT VNS PATIENT HAD PASSED AWAY. TREATING PHYSICIAN INDICATED THAT THE CAUSE OF DEATH WAS SUDEP (SUDDEN UNEXPLAINED DEATH IN EPILEPSY). IT WAS REPORTED THAT THE PT WAS FOUND DEAD IN BED IN THE MORNING WITH NO EVIDENCE OF SEIZURE. TREATING PHYSICIAN INDICATED THAT THE PATIENT EXPERIENCED A >50% REDUCTION IN SEIZURE ACTIVITY WITH THE VNS THERAPY AND WAS RECEIVING THERAPY AT THE TIME OF DEATH. SYSTEM DIAGNOSTICS TESTING PERFORMED AT OFFICE VISIT APPROX THREE MONTHS PRIOR TO DEATH WAS WITHIN NORMAL LIMITS, INDICATING PROPER DEVICE FUNCTION AT THAT TIME. TREATING PHYSICIAN INDICATED THAT THE NCP SYSTEM WAS NOT RELATED TO THE CAUSE OF DEATH. IT WAS REPORTED THAT THE NCP SYSTEM WAS NOT EXPLANTED AND WILL THEREFORE NOT BE RETURNED TO MANUFACTURER FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PULSE GEN MODEL 101 LYJ LYJ CYBERONICS, INC. 101 29648C

Patients

Seq Age Sex Outcome Treatment
1 18 YR Death LAMOTRIGINE| MEDICATIONS AT TIME OF DEATH INCLUDE:| LEVETIRACETAM| BIPOL LEAD MODEL 300-20| IMPLANT DATE: